Spots Global Cancer Trial Database for acute leukemia
Every month we try and update this database with for acute leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL | NCT05071482 | Acute Leukemia | Flumatinib Imatinib | 18 Years - 65 Years | Institute of Hematology & Blood Diseases Hospital, China | |
| Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant | NCT06315309 | GVHD,Acute Acute Leukemia Myelodysplastic... Myeloproliferat... | ATG Combined wi... | 18 Years - 60 Years | University of Alabama at Birmingham | |
| CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia | NCT04157569 | Acute Leukemia | 60 Years - 100 Years | Navy General Hospital, Beijing | ||
| Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation | NCT01810588 | Hematologic Mal... | CliniMACS® CD34... Fludarabine Melphalan anti-thymocyte ... Rituximab Total Body Irra... Mycophenolate M... Tacrolimus | 18 Years - | Weill Medical College of Cornell University | |
| Safety of Romiplostim (Nplate®) Following UCBT | NCT02046291 | Hematologic Mal... | Romiplostim | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings | NCT04969601 | Acute Leukemia Acute Lymphobla... Acute Myeloid L... | vaccine COMIRNA... | 1 Year - 15 Years | Assistance Publique - Hôpitaux de Paris | |
| Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia | NCT04767165 | Acute Leukemia | MRI | 6 Years - 18 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study | NCT04153305 | Myelofibrosis | 18 Years - | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | ||
| Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor | NCT01598025 | Acute Leukemia Chronic Leukemi... Myelodysplastic... Non-Hodgkins Ly... | total-body irra... thiotepa fludarabine pho... melphalan anti-thymocyte ... allogeneic hema... peripheral bloo... laboratory biom... | - 19 Years | Memorial Sloan Kettering Cancer Center | |
| Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia | NCT02693899 | Acute Leukemia | Non Interventio... | 18 Years - | Nantes University Hospital | |
| Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy | NCT02487069 | Acute Leukemia Chronic Myeloid... Myelodysplastic... | HSCT from MSD HSCT from MUD HSCT from HRD Cyclosporin A Methotrexate Antithymocyte g... Mycophenolate m... | 18 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma | NCT03178617 | Acute Lymphobla... Acute Myeloid L... Lymphoblastic L... Acute Leukemia | Educational Int... Educational Int... Quality-of-Life... Questionnaire A... | 5 Years - | City of Hope Medical Center | |
| Dependence Receptors and Leukemia | NCT03278145 | Acute Lymphobla... Acute Leukemia | Genetic analyse... | 1 Year - 18 Years | Hospices Civils de Lyon | |
| Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies | NCT01385072 | Relapsed and Re... | Double matched ... | 18 Years - | Rabin Medical Center | |
| Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy | NCT03279900 | Acute Leukemia | 1 Year - 18 Years | Indonesia University | ||
| Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort) | NCT02344953 | Acute Leukemia | 16 Years - | Yonsei University | ||
| Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation | NCT04339101 | Acute Leukemia Hematologic and... Myelodysplastic... Primary Myelofi... Secondary Myelo... | Fludarabine Itacitinib Adip... Melphalan Quality-of-Life... Questionnaire A... Sirolimus Tacrolimus | 18 Years - 75 Years | City of Hope Medical Center | |
| Expression of Aberrant CD Markers in Acute Leukemia:Retrospective Study in South Egypt Cancer Institute | NCT03743909 | Acute Leukemia | - | Assiut University | ||
| Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia | NCT03408223 | Acute Leukemia | total body irra... total marrow an... | 8 Years - 65 Years | Affiliated Hospital to Academy of Military Medical Sciences | |
| CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT | NCT03810196 | Acute Leukemia Acute Myeloid L... Myelodysplastic... Acute Lymphobla... Mixed Lineage L... Lymphoblastic L... Burkitt Lymphom... Juvenile Myelom... | CliniMACS Cell ... | - 25 Years | Children's Hospital of Philadelphia | |
| Feasiblity and Safety of Home-based Intensive Chemotherapy | NCT04904211 | Acute Leukemia | Home-based chem... | 18 Years - | Rigshospitalet, Denmark | |
| Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML) | NCT01242774 | Acute Myeloid L... | Panobinostat | 18 Years - 65 Years | Novartis | |
| Trial of AVN-944 in Patients With Advanced Hematologic Malignancies | NCT00273936 | Acute Leukemia Chronic Leukemi... Multiple Myelom... Hodgkin's Lymph... Non-Hodgkin's L... Waldenstrom's M... | AVN-944 capsule... | 18 Years - | Vertex Pharmaceuticals Incorporated | |
| Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis | NCT06058858 | Cytomegalovirus... Acute Leukemia B Cell Lymphoma | 1 Year - 100 Years | Assistance Publique - Hôpitaux de Paris | ||
| Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients | NCT02877082 | Acute Leukemia Chronic Lymphoc... Chronic Myeloge... Diffuse Large B... Follicular Lymp... Graft Versus Ho... Mantle Cell Lym... Marginal Zone L... Myelodysplastic... Myelofibrosis Myeloproliferat... Small Lymphocyt... | Thymoglobulin Bortezomib Tacrolimus | 18 Years - 75 Years | Emory University | |
| Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) | NCT03970096 | Acute Leukemia Acute Lymphobla... Acute Myeloid L... Myelodysplastic... | Total-Body Irra... Thiotepa Fludarabine Tacrolimus Allogeneic CD34... Methotrexate Cyclophosphamid... Peripheral Bloo... Cyclosporine Sirolimus Busulfan Bone Marrow Asp... Echocardiograph... Multigated Acqu... Biospecimen Col... | 1 Year - 60 Years | Fred Hutchinson Cancer Center | |
| Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation | NCT05005299 | Leukemia, Myelo... Leukemia, Lymph... Leukemia, Lymph... Myelodysplastic... Non-hodgkin Lym... Plasma Cell Mye... | Venetoclax Fludarabine Cyclophosphamid... | 18 Years - 75 Years | Melbourne Health | |
| Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome | NCT01314599 | Acute Leukemia | PM01183 1 mg Po... | 18 Years - | PharmaMar | |
| Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System | NCT00520130 | Myelodysplastic... Hodgkin's Lymph... Non-Hodgkin's D... Acute Leukemia Multiple Myelom... | Rituximab Cyclosporine Allogenic stem ... Conditioning Ch... TMS FLAG EPOCH-F Alemtuzumab | 18 Years - 74 Years | National Institutes of Health Clinical Center (CC) | |
| Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation | NCT05634915 | Hematopoietic S... Acute Leukemia | Individual ATG ATG | 16 Years - 60 Years | The First Affiliated Hospital of Soochow University | |
| Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia | NCT05335226 | Acute Leukemia | Combined haploi... haploidentical ... | 18 Years - 65 Years | Institute of Hematology & Blood Diseases Hospital, China | |
| Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematologic Cancers. | NCT03698656 | Acute Leukemia Lymphoma | Spiritual Inter... | 18 Years - | University Hospital, Toulouse | |
| Evaluation of Bibliotherapy by Students and Patients With Cancer | NCT03969082 | Acute Leukemia Advanced Solid ... | Bibliotherapy | 18 Years - | University Hospital, Ghent | |
| Monitoring the Diagnosis and Management of Acute Leukaemia In Pregnancy Study. | NCT04182074 | Acute Leukemia | - | University of Hull | ||
| Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY | NCT00809276 | Lymphoma Multiple Myelom... Leukemia Myelodysplastic... | Busulfan, Fluda... | - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies | NCT05316701 | Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Undifferentiate... Myelodysplastic... Acute Leukemia Therapy-Related... | Orca-T Standard-of-Car... | 18 Years - 65 Years | Orca Biosystems, Inc. | |
| Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders | NCT03314974 | Acute Leukemia Acute Myeloid L... Acute Lymphobla... Lymphoma Chronic Myeloge... Plasma Cell Leu... Myeloproliferat... Myelofibrosis Myelodysplasia Refractory Anem... High Risk Anemi... Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Diffuse Large C... Lymphoblastic L... Burkitt Lymphom... High Grade Non-... Multiple Myelom... Juvenile Myelom... Biphenotypic/Un... MRD Positive Le... Natural Killer ... Acquired Bone M... | HSCT with TBI R... HSCT with Non-T... | - 60 Years | Masonic Cancer Center, University of Minnesota | |
| PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation | NCT05120570 | Acute Leukemia Myelodysplastic... Myeloproliferat... Lymphoma | VIC- 1911 | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Cryopreserved MMUD BM With PTCy for Hematologic Malignancies | NCT05170828 | Acute Leukemia Myelodysplastic... T-lymphoblastic... Acute Lymphocyt... Acute Myeloid L... Acute Biphenoty... Acute Undiffere... | Cyclophosphamid... Fludarabine Total Body Irra... Busulfan Mesna Sirolimus Mycophenolate M... Filgrastim Cyclophosphamid... Bone Marrow Tra... | 18 Years - 70 Years | Ossium Health, Inc. | |
| Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings | NCT04969601 | Acute Leukemia Acute Lymphobla... Acute Myeloid L... | vaccine COMIRNA... | 1 Year - 15 Years | Assistance Publique - Hôpitaux de Paris | |
| Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) | NCT03792256 | Leukemia, Lymph... Lymphoblastic L... T-cell Lymphoma T-cell Leukemia Recurrent Disea... Acute Leukemia | Palbociclib Cytarabine Methotrexate Hydrocortisone Doxorubicin Prednisolone Vincristine Pegaspargase Hydrocortisone Prednisone | 12 Months - 31 Years | Children's Oncology Group | |
| Immunophenotyping of Acute b Cell Lymphoblstic Leukemia | NCT04084327 | Acute Leukemia | stastical analy... | 12 Months - 80 Years | South Egypt Cancer Institute | |
| Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation | NCT01596257 | Leukemia | allogeneic hema... CliniMACS | - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell | NCT01660607 | Myeloid Leukemi... Acute Myelogeno... Myelodysplastic... Lymphoma, Non-H... Acute Lymphobla... Myeloproliferat... Acute Myeloid L... Acute Leukemia Chronic Myeloge... | Conventional T ... | 13 Years - 60 Years | Stanford University | |
| Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells | NCT01624701 | Acute Leukemia Chronic Leukemi... Myelodysplastic... Lymphoma Myeloma | Ex vivo expande... | 12 Years - 60 Years | Singapore General Hospital | |
| Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study | NCT05053100 | Acute Leukemia Deep Vein Throm... Hematopoietic a... Hodgkin Lymphom... Myeloproliferat... Non-Hodgkin Lym... Plasma Cell Mye... Thrombocytopeni... | Biospecimen Col... Electronic Heal... | 18 Years - | Mayo Clinic | |
| Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant | NCT06265584 | Acute Leukemia Myelodysplastic... Myeloproliferat... | ATG dosing plat... | 18 Years - 75 Years | University of Alabama at Birmingham | |
| Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System | NCT00520130 | Myelodysplastic... Hodgkin's Lymph... Non-Hodgkin's D... Acute Leukemia Multiple Myelom... | Rituximab Cyclosporine Allogenic stem ... Conditioning Ch... TMS FLAG EPOCH-F Alemtuzumab | 18 Years - 74 Years | National Institutes of Health Clinical Center (CC) | |
| Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia | NCT03672851 | Acute Leukemia Acute Leukemia ... Acute Myeloid L... Relapsed or Ref... | anti-CD123 CAR-... | - | Second Affiliated Hospital of Xi'an Jiaotong University | |
| Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study | NCT01557686 | Acute Leukemia | Health counseli... | 18 Years - | Universitetshospitalernes Center for Sygepleje | |
| Change of Fatigue and Physical Fitness in Hospitalized Hematology Patients | NCT01603290 | Acute Leukemia | 20 Years - | National Taiwan University Hospital | ||
| Implementation of Innovative Techniques in Routine Diagnosis of Childhood Acute Leukemia: Analysis of Genome and Transcriptome by Micro-array | NCT02038361 | Acute Leukemia | blood draw | 0 Years - 18 Years | Assistance Publique Hopitaux De Marseille | |
| Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients | NCT05974410 | Glioblastoma Squamous Cell C... Hodgkin Lymphom... Non-hodgkin Lym... Breast Cancer Prostate Cancer Gastric Cancer Ovarian Cancer Acute Leukemia Pancreatic Canc... Spindle Cell Sa... Cancer Tumor, Solid Tumor, Brain | AVM0703 Hydrocortisone Proton pump inh... | - | AVM Biotechnology Inc | |
| Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia | NCT06001788 | AML AML With Mutate... Hematologic Mal... KMT2Ar NPM1 Mutation MLL Rearrangeme... Leukemia Acute Myeloid L... Leukemia, Myelo... Leukemia, Myelo... Acute Leukemia Neoplasms by Hi... | Ziftomenib Fludarabine Idarubicin Cytarabine Gilteritinib Granulocyte col... | 18 Years - | Kura Oncology, Inc. | |
| Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation | NCT01800643 | Acute Leukemia Chronic Leukemi... Lymphoprolifera... Myeloproliferat... Immunodeficienc... | Analyze the pha... | - | Hospital Israelita Albert Einstein | |
| Dependence Receptors and Leukemia | NCT03278145 | Acute Lymphobla... Acute Leukemia | Genetic analyse... | 1 Year - 18 Years | Hospices Civils de Lyon | |
| HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis | NCT06001385 | Acute Lymphobla... Acute Myeloid L... Acute Leukemia Myelodysplastic... Chronic Myeloid... Chronic Lymphoc... Myeloproliferat... Lymphoma Chronic Myelomo... Pro-Lymphocytic... Myelofibrosis | Busulfan Fludarabine PBSC Hematopoie... Post-Transplant... Mesna Tacrolimus Mycophenolate M... Patient Reporte... Melphalan Total-body irra... Cyclophosphamid... | 18 Years - | Center for International Blood and Marrow Transplant Research | |
| Decitabine, Cytarabine, GCSF for Refractory AML/MDS | NCT00740181 | Myelodysplasia Leukemia | chemotherapy | 19 Years - | Brown University | |
| Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation | NCT01800643 | Acute Leukemia Chronic Leukemi... Lymphoprolifera... Myeloproliferat... Immunodeficienc... | Analyze the pha... | - | Hospital Israelita Albert Einstein | |
| Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia | NCT02693899 | Acute Leukemia | Non Interventio... | 18 Years - | Nantes University Hospital | |
| Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia | NCT02353559 | Acute Leukemia | EASE | 18 Years - | University Health Network, Toronto | |
| Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders | NCT03314974 | Acute Leukemia Acute Myeloid L... Acute Lymphobla... Lymphoma Chronic Myeloge... Plasma Cell Leu... Myeloproliferat... Myelofibrosis Myelodysplasia Refractory Anem... High Risk Anemi... Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Diffuse Large C... Lymphoblastic L... Burkitt Lymphom... High Grade Non-... Multiple Myelom... Juvenile Myelom... Biphenotypic/Un... MRD Positive Le... Natural Killer ... Acquired Bone M... | HSCT with TBI R... HSCT with Non-T... | - 60 Years | Masonic Cancer Center, University of Minnesota | |
| Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia | NCT04674345 | Acute Leukemia Relapse Hematopoietic S... | Sorafenib | 18 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies | NCT04710212 | Hematologic Mal... Leukemia, Acute Neutropenia Bloodstream Inf... | No intervention... | 18 Years - | Duke University | |
| Olverembatinib for FGFR1-rearranged Neoplasms | NCT05521204 | Myeloproliferat... Acute Leukemia | Olverembatinib | - | The First Affiliated Hospital of Soochow University | |
| Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy | NCT02445378 | Acute Leukemia Anorexia Anxiety Depression Dyspnea Insomnia Nausea Pain | Aromatherapy an... Placebo Questionnaire A... | - | Ohio State University Comprehensive Cancer Center | |
| A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation | NCT04065399 | Acute Myeloid L... Acute Lymphobla... Mixed Lineage A... Mixed Phenotype... Acute Leukemia ... | revumenib cobicistat | 30 Days - | Syndax Pharmaceuticals | |
| Cytogenetic Studies in Acute Leukemia and Multiple Myeloma | NCT00048958 | Acute Leukemia Acute Lymphobla... Myelodysplastic... Multiple Myelom... | cytogenetic ana... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Cancer Stem Cells in Acute Leukemia | NCT03735797 | Acute Leukemia | Bone marrow asp... | 1 Month - 30 Years | Sanford Health | |
| Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction | NCT03316456 | Chemotherapy-In... Acute Leukemia | Observational: ... Observational: ... Observational: ... | 18 Years - 99 Years | Masonic Cancer Center, University of Minnesota | |
| Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells | NCT01624701 | Acute Leukemia Chronic Leukemi... Myelodysplastic... Lymphoma Myeloma | Ex vivo expande... | 12 Years - 60 Years | Singapore General Hospital | |
| Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors | NCT00701844 | Leukemia Acute Leukemia Acute Lymphocyt... Multiple Myelom... Hematological C... Psychological D... | Writing A (Expe... Writing B (Expe... Writing C (Cont... Writing D (Cont... | 18 Years - | University of North Carolina, Chapel Hill | |
| Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study | NCT01557686 | Acute Leukemia | Health counseli... | 18 Years - | Universitetshospitalernes Center for Sygepleje | |
| Association Between Telomere Length and Cardiac Dysfunction | NCT04409379 | Cardiac Toxicit... Acute Leukemia Childhood Cance... | Relative telome... | 1 Year - 16 Years | Air Force Military Medical University, China | |
| Respiratory Syncytial Virus - RSV Protocol | NCT01502072 | Bone Marrow Tra... Infection in Ma... Respiratory Syn... Respiratory Syn... Cancer Acute Leukemia | Ribavirin Ribavirin | 18 Years - | M.D. Anderson Cancer Center | |
| Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia | NCT03756675 | Acute Leukemia | haplotype PBSCT | 2 Years - 60 Years | Peking University People's Hospital | |
| Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors | NCT00701844 | Leukemia Acute Leukemia Acute Lymphocyt... Multiple Myelom... Hematological C... Psychological D... | Writing A (Expe... Writing B (Expe... Writing C (Cont... Writing D (Cont... | 18 Years - | University of North Carolina, Chapel Hill | |
| Cytogenetic Studies in Acute Leukemia and Multiple Myeloma | NCT00048958 | Acute Leukemia Acute Lymphobla... Myelodysplastic... Multiple Myelom... | cytogenetic ana... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Phase I Study of Lenalidomide in Patients With Acute Leukemia | NCT01615042 | Acute Leukemia | Lenalidomide | 18 Years - 80 Years | University of California, Davis | |
| Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome | NCT01314599 | Acute Leukemia | PM01183 1 mg Po... | 18 Years - | PharmaMar |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
